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The ~5’ CP f- lasma desorption (PD) mass spectrum of the nonapeptide bradykinin was 
studied in detail with particular emphasis on the fragmentation pattern resulting from fast 
metastable decay of the molecular ion. N-acetyl and O-methyl derivatives of bradykinin 
were used as mass shift species for assignment of N-terminal and C-terminal fragment ions. 
Thirty-seven sequence-specific fragment ions were identified, including those that are due 
to cleavage of peptide backbone as well as side chain bonds (i.e., d,, v,,, w,, fragment ions). 
The degree of fragmentation correlates with what has been observed by fast atom bombard- 
ment tandem mass spectrometry using hi 
of excitation of bradykinin molecules in g, 
h energy collisional activation. The high degree 
52Cf-PDMS 
nature of excitation intrinsic to the 252Cf-PD 
is undoubtedly due to the specia1 
process where electronic excitation occurs with 
a very high probability due to the high electron and photon flux surrounding the nuclear 
fission fragment track. 
These results offer further evidence that 252Cf-PDMS I in addition to providing molecular 
weight information, can be used to sequence peptides without the need for a second stage 
of molecular excitation. (J Am SIX Mass Spectrom 1991, 2, 379-386) 
U sed in the determination of the molecular weights of a wide spectrum of complex molecules of biological interest [l], more re- 
cently 25ZCf-plasma desorp tion mass spectrometry 
(252Cf-PDMS) has been equally successful with metal 
cluster compounds with masses approaching 100 kD 
PI. 252Cf-PDMS remains as one of the most univer- 
sally applicable mass spectrometric methods. One of 
the features of the method is its simplicity and reliabil- 
ity of operation, which has led to its adoption in a 
number of biomedical laboratories as a standard ana- 
lytical instrument. A perceived limitation of the 
method is that little structural information can be 
obtained from a z5zCf-PD mass spectrum. Conse- 
quently, 252Cf-PDMS has been sometimes referred to 
as an efficient “molecular weight machine” [3]. Part 
of the reason for this misconception is due to the 
emphasis that had been placed on extending the mass 
range capability of Z52Cf-PDMS for the studies of 
biopolymers with increasing molecular mass. This has 
involved a considerable effort in improving the instru- 
mentation and finding new adsorption/desorption 
matrices for enhancing the yield of high mass protein 
molecular ions. These activities were carried out at the 
ex zrp ense of exploiting the features that were present in Ci-PD mass spectra, namely, fragmentation pat- 
terns that could be correlated with structure, Even 
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though we recognized in our first measurements in 
the early days of the development of 252Cf-PDMS that 
fragment ions were present in *“Cf-PD mass spectra 
[4], only for a few studies in our laboratory were 
fragmentation patterns analyzed for the purpose of 
obtaining structure information, 
One of the fmst extensive uses of fragmentation 
patterns generated by %If-PDMS for structural stud- 
ies was carried out by McNeal et al. [5] in their 
characterization studies of synthetic oligonucleotides 
where an intense negative ion fragmentation pattern 
was observed due to the weakness of the oligonu- 
cleotide’s phosphodiester bond. Chait et al. [6] were 
the frrst to utilize the fragmentation pattern in a 252ff- 
PD mass spectrum of a peptide to verify the sequence 
of synthetic alamethicin I which contains 20 amino 
acid residues. Fales et al. [7], in a study of polymeth- 
ylenediamine-linked enkephalin peptides, showed 
that the 252Cf-l’D mass spectra of these species con- 
tamed not only the peptide fragment ions, but also a 
complete cleavage pattern of the polymethylene link, 
an excellent example of “charge-remote site” frag- 
mentation that was frrst recognized by Tomer et al. 
[8]. Roepstorff et al. [9] reported the fragmentation of 
the pentacylic peptide Nisin, although the extent of 
fragmentation was completely dependent on the sam- 
ple preparation method. Despite these earlier positive 
indications, the use of zszCf-PDMS for sequence de- 
termination has not been vigorously pursued and the 
general view of the potential for ?XPDMS as a 
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sequencing method has been unjustifiably pessi- 
mistic. 
Recent studies by Vorst et al. [lo] and Buko and 
Sarin [ll] have shown that complete sequence infor- 
mation could be obtained from the primary ‘“Cf- 
PDMS spectrum (primary in the sense that no addi- 
tional fragmentation of the primary, desorbed ions is 
used) for native peptides up to 5.5 kD and suggest 
that the fragmentation is comparable to what is ob- 
served by using fast atom bombardment tandem mass 
spectrometry (FABMS/MS) coupled with high energy 
collision-induced dissociation (CID). This exciting new 
development has encouraged us to begin an extensive 
program to study the possibilities of using the pri- 
mary s2Cf-PD mass spectrum to sequence peptides 
and proteins. Our hrst results are reported here. 
Bradykinin was the model peptide chosen for this 
work because its fragmentation has been extensively 
characterized over a wide range of excitation energies. 
The frrst objective of this study was to record the 
fragmentation pattern and use established protocols 
for resolving fragment ion peaks from those of the 
matrix. The second objective was to determine the 
excitation energy regime for 252Cf-PDMS by compari- 
son of our fragmentation patterns for bradykinin with 
those obtained by others from direct excitation in FAB 
[12], by the decay of FAB-generated metastable molec- 
ular ions [13], and by CID of FAB-generated molecu- 
lar ions in the low- and high-ion velocity regime [14]. 
the mass accuracy for all ions and resulted in mass 
errors that were both positive and negative in sign. 
The H- and C,H- ions were used to calibrate the 
negative PD mass spectra. 
Purilications and separation of bradykinin and 
derivatives were carried out by using a reverse phase 
high performance liquid chromatography (HPLC) col- 
umn (Applied Biosystems Aquapore Cs RF’-300, 1 x 
50 mm) connected to a microseparations system 
(Model 130A, Applied Biosystems, Foster City, CA). 
Chromatograms were obtained by using a data mod- 
ule (Model 7458, Waters, Milford, MA). 
Reagents and Samples 
Bradykinin (Serva, Westbury, NY) was purified just 
prior to use by reverse phase HPLC using the system 
described above. Acetic anhydride (Mallinckrodt, 
Paris, NY), sodium acetate and concentrated hydro- 
chloric acid (HCI) (Fisher, Fair Lawn, NJ), and 
methanol (Burdick & Jackson, Muskegon, MI), as well 
as solvents used in the HPLC separations were used 
without further puri6cation. 
Sample Preparation and Synthesis 
Experimental 
Instrumentation 
Mass spectra were recorded on a ‘?f-PD mass spec- 
trometer that was designed and built in our labora- 
tory. Details of this system have been published [15]. 
A 7pCi E2Cf source (Isotope Products, Inc., Burbank, 
CA) was positioned 4 mm behind the sample target, 
giving an effective fission fragment flux through the 
sample of 2100/s. An acceleration voltage of +15 kV 
was used for positive ions, and - 10 kV for negative 
ions. The length of the field-free region was 52 cm, 
and a new ion detector, consisting of two 40-mm 
diameter microchannel plates coupled by an electron 
focusing lens to a 25mm diameter impedance matched 
anode, was used at the end of the flight tube. This 
detector gives improved sensitivity. Data accumula- 
tion time was increased to 720 min for these measure- 
ments to enhance signal/background ratios for low 
intensity ions. 
The peptide samples for PDMS were purified by re- 
verse phase HPLC using a linear binary gradient elu- 
tion with 0.1% trifluoroacetic acid (TFA) as the aque- 
ous component and 0.1% TFA in 80% acetonitrile as 
the organic component. Approximately 250 pmol of 
peptide were injected onto the HPLC column. When 
the peptide fraction was eluted from the column (ca. 
25 PL elution volume), it was collected directly onto a 
Z5ZCf-PDMS sample holder consisting of an electro- 
sprayed nitrocellulose coating (100 pg/cm2) sup- 
ported on a 1.5-pm thick aluminized polyethylene 
terephthalate film. This is referred to in later discus- 
sions as the sample target. We collected the peptide 
fraction directly onto the target to minimize sample 
loss and reduce the possibility of introducing contami- 
nants. The peptide fraction was then evaporated to 
dryness under a stream of nitrogen to ensure satura- 
tion coverage of the nitrocellulose by the peptide. A 
droplet of water was then applied to the surface of the 
peptide/nitrocellulose deposit and allowed to stand 
for a few seconds to redissolve water-soluble impuri- 
ties and peptide that was not firmly adsorbed to the 
nitrocellulose. The droplet was removed by centrifu- 
gation at 8000 rpm by using a photoresist spinner 
(Headway Research, Garland, TX). 
Mass calibration of the positive I’D mass spectra Acetylation of the N-terminal amine of bradykinin 
was accomplished using the H+, C,Hi, and phenyl- was carried out by using an established procedure 
alanine immonium (m/z 120) ions. Using just the H+ [17]. Bradykinin (1 pmol) was dissolved in an equal 
and C,H$ ions for mass calibration resulted in the volume of water and a saturated solution of sodium 
observed masses for all of the molecular and fragment acetate (pH = 9.2). A hundredfold molar excess of 
ions to be lower than their calculated masses [16]. We acetic anhydride was then added to the peptide solu- 
have found that incorporating the higher mass phenyl- 
alanine immonium ion into the calibration improved 
tion in four equivalent aliquots at 0 ‘C over a period 
of 1 hr. The reaction products was separated by HPLC, 
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and the singly acetylated fraction was collected on a 
nitrocellulose target and analyzed by 252Cf-PDMS. 
The yield of the N-term&J acetylated bradykinin was 
estimated from the HPLC chromatogram to be ap- 
proximately 90%. A second fraction comprising the 
remaining 10% was found by 252Cf-PDMS to be the 
diacetylated peptide with the second acetyl group 
located on a serine residue. 
To prepare the C-terminal methyl ester analog of 
bradykinin, 1 Fmol of the peptide was dissolved in 
methanolic 0.01 N HCl and reacted for 12 h at 5 ‘C 
[17]. The HCl/methanol solution was prepared by 
adding concentrated HCl to methanol. The reaction 
products were separated by HPLC, collecting the de- 
sired product fraction directly on a nitrocellulose tar- 
get. Prom the HPLC chromatogram, the yield of the 
bradykinin methyl ester was estimated to be 60%, 
with the remainder being the unreacted peptide. 
Results and Discussion 
General Plan 
This study is part of a long-term goal to develop 
%.3-PDMS as a pep tide sequencing method, so we 
deemed it necessary to establish a general protocol to 
determine unequivocally which ions in the =Cf-PD 
mass spectrum were indeed fragment ions from 
bradykinin. Because we wish to use only the primary 
mass spectrum for the sequence determination, we 
must hrst distinguish background ions from the 
bradykinin fragment ions. The nitrocellulose sub- 
strate, which may also contain adsorbed molecules 
from the ambient residual gas in the mass spectrome- 
ter, is the main source of background ions. A 252Cf-PD 
mass spectrum of the nitrocelIulose target without 
adsorbed bradykinin gives some indication of the ma- 
jor substrate ion peaks in the mass region of interest 
that may also appear in the bradykinin spectrum. 
Background ions can also come from impurities in the 
bradykinin sample that coelute with bradykinin in the 
HPLC fraction and coadsorb onto the nitrocellulose. 
By using a high resolution microbore column in the 
HPLC purification, this contribution is minimized. 
After an ensemble of peaks has been identified in 
the bradykinin spectrum as candidate fragment ions, 
the final criterion that a candidate fragment ion is 
indeed a real fragment ion is that an appropriate mass 
shift is observed for that peak in the mass spectrum of 
either the N-terminal or C-terminal derivatived pep- 
tide. This technique has been previously used to iden- 
tify N-terminal and C-terminal fragment ions [18]. 
The Positive Ion Mass Spectrum of the 
Nifrocellulose Substrate in the Region of Znferest 
The positive ion spectrum of nitrocellulose in the 
mass region of interest (m/z 195-1160) recorded for a 
720-min period is shown in Figure la . The spectrum 
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contains a number of prominent ions in this mass 
region and an assortment of ion peaks with lower 
intensity. The most prominent ions that persist when 
bradykinin is adsorbed onto the surface are at m/z 
219, 280, 391, 419, and 570. No attempt has been 
made to identify the structure of these ions. 
The Positive Ion Mass Spectrum of Brady&in 
Adsorbed on Nitrocellulose 
The 252Cf-PD positive ion spectrum of bradykinin 
(RPPGFSPFR) adsorbed on nitrocellulose in the mass 
region m/z 195-1160 is shown in Figure lb. The most 
prominent ion is the bradykinin molecular ion at m /z 
1061.21 f 0.20, a mass that is in good agreement with 
the isotopically averaged mass of the protonated 
molecular ion (calculated, 1061.23 u). The doubly pro- 
tonated species was also observed at m/z 530.98 * 
0.20 (calculated, 531.12 u). 
In the first analysis of the bradykinin fragmenta- 
tion spectrum the primary concern was whether the 
background contriition from the nitrocellulose ma- 
trix would give too much interference. Fortunately, 
some of the ions that are due to the nitrocellulose are 
significantly attenuated in intensity when the 
bradykinin is adsorbed on the surface. For example, 
the prominent peaks at m/z 219, 280, and 391 are 
reduced in intensity by 70% when bradykinin is ad- 
sorbed, suggesting that these ions originate from ad- 
sorption/desorption sites on the nitrocellulose strut- 
ture. In addition to the ions that were known to 
originate from the substrate, 37 structurally significant 
(M+H) 
Mass (m/z) 
Figure 1. Positive ion plasma desorption mass spectra of (a) 
nitrocellulose and (b) bradykiiin adsorbed on nitrocellulose, 
indicating the nitrocellulose mati peaks present in both spec- 
tra. 
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ions were identified as originating from fragmentation 
of the protonated (or, possibIy, doubly protonated) 
molecular ion of bradykinin. The total intensity (in- 
tegrated peak areas) of the fragmentation ion spec- 
trum was found to be comparable to the sum of the 
intensities of the protonated and doubly protonated 
molecular ion. These ions are listed in Table 1. 
The Positive Ion Spectra of N-acetylated 
and 0-methylated Bradykinin Adsorbed 
on Nitrocellulose 
The objective of this series of experiments was to 
determine whether the complex pattern of fragment 
ions observed in the native bradykiin spectrum could 
be resolved into the two classes of N-terminal and 
C-terminal fragment ions. This was accomplished 
by preparing N- and C-terminal derivatives of 
bradykinin: N-acetyl bradykinin and O-methylated 
bradykinin. Both derivatives were prepared by using 
standard methods outlined in the Experimental sec- 
tion, followed by purification by microbore HPLC. All 
peaks in the primary bradykinin spectrum that were 
shifted by 42 u in the spectrum for the N-acetyl 
derivative were assigned to N-terminal fragment ions; 
those that shifted in mass by 14 u for the O-methyl- 
ated derivative were assigned to C-terminal fragment 
ions. Those peaks that did not shift for either deriva- 
tive can only be due to background peaks OK internal 
fragmentation of the peptide. 
The mass spectra for bradykinin and the two 
derivatives have been divided into three mass regions 
and are shown in Figures 2-4. Figure 2 covers the 
mass region from m/z 195-500. Two examples of the 
mass shift method are depicted. The peak at m/z 
254.25 in the bradykinin spectrum (Figure 2b) was not 
present in the spectrum of the N-acetylated derivative 
(Figure 2a), but was present in the spectrum of the 
0-methylated derivative (Figure 2~). The assignment 
of this peak as an N-terminal fragment ion was con- 
timed by the presence of a new peak in the spectrum 
of the N-acetylated derivative that is shifted in mass 
by 42 u. This peak was subsequently designated as a 
b2 fragment ion (using the notation of Roepstorff and 
Fohlman [19], with the modifications suggested by 
Biemann [20]), having a calculated M/Z of 254.31. In a 
similar manner, the peak at m/z 348.30 was identified 
as a C-terminal fragment ion from the observation 
that this peak was still present in Figure Za, but was 
absent in Figure 2c with a new peak appearing 14 u 
higher. This peak was subsequently designated as the 
x2 fragment ion (calculated m/z = 348.38). This pro- 
cedure was used to identify the majority of the peaks 
in the bradykinin spectrum in this mass region and to 
identify which ions are not from bradykinin. For ex- 
ample, the peak m /.z 279.4, present in all three spec- 
tra and in the bare nitrocellulose spectrum (Figure la), 
is clearly a peak from the background. 
J Am 5.0~ Mass Spectrom 1991,2,379-3+X 
Table 1. Moleculsr md frament ions of bradvkinin 
Ion Observed 
i 
Calculated Relative 
mass’ (u) mass’ Iu) intensity b 
(M + H)+ 1061.21 1061.23 1 .oo 
(M + 2H)‘+ 530.98 531.12 0.13 
a2 226.29 226.30 0.14 
*3 323.37 323.42 0.14 
a4 380.39 380.47 0.04 
a5 527.45 527.65 0.11 
a6 614.75 614.72 0.05 
87 711.76 711.84 0.07 
aB 859.44’ 859.02 0.06 
b 254.25 254.31 0.04 
b, 400.39 408.48 0.01 
b, 642.69 642.73 0.03 
c3 + 2 368.41 368.46 0.01 
cq + 2 425.41 425.51 0.02 
cs + 2 572.80 572.69 0.02 
c, + 2 757.06 756.88 0.01 
c* + 2 903.95d 904.06 0.04 
de 598.89 598.72 0.04 
ds 931.008 930.10 0.03 
y2 230.24 230.25 0.07 
vq 474.29 474.54 0.03 
“5 561.63 561.62 0.02 
w3 376.48 376.43 0.02 
w7 765.21 764.86 0.01 
Xl 201.20 201.20 0.09 
x2 348.30 348.38 0.04 
x,+ 1 446.48 446.51 0.05 
x5 679.85 679.75 0.02 
x6 736.62 736.80 0.03 
x, + 1 834.87 834.93 0.01 
xs + 1 931 .OO’ 932.05 0.03 
V3 417.49 417.48 0.08 
V7 805.77 805.91 0.03 
Ys 903.95d 903.02 0.04 
z, + 1 159.20 159.19 0.16 
z*+ 1 306.34 306.36 0.06 
z,+ 1 490.38 490.56 0.02 
zs+ 1 637.26 637.73 0.01 
zs + 1 695.22 694.78 0.01 
-R,r, 960.86 961.08 0.04 
-Rptls 969.56 970.09 0.02 
-R,,r 1030.30 1030.02 0.03 
-COOH 1015.94 1016.21 0.06 
-NH, 1043.79 1044.20 0.02 
‘lootopically averaged mass 
b Relative to bradykinin [M + !-t] + 
: as /a8 + 1 unresolved 
cg + 2 and y8 ions unresolved 
‘d, and xs + 1 ions unresolved 
Figure 3 covers the mass range of m/z 500-790 for 
bradykinin and the two derivatives. Two more exam- 
ples of fragment ion assignments based on mass shifts 
are graphically presented: the ion at m/z 598.89, 
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Figure 2. Positive ion mass spectra of (a) N-acetylated 
bradykinin, @) bradykinin, and (c) 0-methykted bradykinin in 
the mass range 195 to 500 u. 
which was determined to be an N-terminal fragment 
ion and was subsequently assigned as a d, fragment 
ion (calcuIated m/z = 59&X.72), and an ion at m/z 
679.85, a C-terminal fragment ion identified as an xa 
fragment ion (calculated m/z = 679.75). The intensity 
of the doubly protonated molecuIar ion that appears 
in this mass region is not affected by the presence of 
the functional groups that are added to the molecule. 
Figure 4 covers the mass region from m/z 790-1160 
and includes the molecular ion plus the heaviest N- 
and C-terminal fragments. The peak at m/z 903.95 in 
the native bradykinin spectrum (Figure 4b) could be 
assigned as either a ys (calculated m/z = 903.02) or a 
cs -t 2 (calculated m/z = 904.06) ion. In the spectrum 
of the 0-methylated bradykinin (Figure 4c), these two 
ions are resolved due to the 14-u mass shift of the 
C-terminal ys ion. Therefore, the m/z 903.95 peak in 
the native bradyklnin can be attributed to unresolved 
ys and cs + 2 ions. Likewise, the m/z 931.00 peak in 
the native bradykinin spectrum can be assigned to 
both a ds (calculated m/z = 930.10) and an xs + 1 
(calculated m/z = 932.05) ion through the appropri- 
ate mass shifts in the spectra of both derivatives. 
In addition to the appearance of N-terminal and 
1.00 
0.50 v, 
4 B 
b 
; 2.00 
B 1.50 
1 
5 1.00 
E3 
s 0.50 
550 600 650 700 750 
I 
li 
Mass (m/z) 
Figure 3. Positive ion mass spectra of (a) N-acetylated 
bradykinin, (b) bradykiiin, and (c) 0-methylated bradykinin in 
the mass range 500 to 790 u. 
C-terminal fragment ions, a collection of peaks ap- 
pears near the mass of the molecular ion that corre- 
sponds to the loss of neutral molecules and side 
chains from some of the amino acid components of 
bradykinin. For example, weak peaks corresponding 
to loss of - NH, are observed for the native molecule 
and the methyl ester. Loss of -COOH is a strong 
fragment ion for the parent molecule and the N-acetyl 
derivative but is absent for the O-methyl ester, being 
replaced by loss of -COOCH,. Side chain losses 
from serine, arginine, and phenylalanine residues are 
also observed. A weak peak (1% of the intensity of 
the [M + HI+ ion) was also observed at m/z 1077, 
which we attribute to a minor contaminant of the 
sample. Because of its low abundance, this contami- 
nant does not measurably contribute to the fragmen- 
tation ion spectrum. 
The results of the fragmentation pattern analysis 
for bradykinin including the fragment type, observed 
and calculated mass, and the relative intensity are 
summarized in Table 1. The average error in mass for 
the data set was determined to be - .05 + 0.20 u. 
The fragmentation pattern for bradykinin is rich 
with structural information and is easily discernible 
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Figure 4. Positive ion mass spectra of (a) N-acetylated 
bradykinin, (b) bradykinin, and (c) 0-methylated bradykinin in 
the maw range 790 to 1160 u. 
from the background peaks. An inventory of the ions 
detected in the bradykinin spectrum shown in Figure 
lb has revealed some interesting statistics. Approxi- 
mately 9.5 million positive ions originating from 
bradykinin were detected in the 12-h acquisition that 
were either molecular ions or sequence-specific ions. 
For the molecular ion component, 47% of the total 
comprised the protonated molecular ion; 3% the dou- 
bly protonated ion. The remaining 50% were dis- 
tributed as N-terminal fragment ions (27%), C-termi- 
nal fragment ions (13%), and fragment ions resulting 
from neutral molecule loss from the molecular ion 
(10%). 
The fragmentation pattern is dominated by the 
a,, /a, + 1 series, which forms a doublet pattern that 
is resolved at low mass (Figure 2b) but not at high 
mass (Figure 3b). Additional N-terminal fragment ions 
include not only representatives from the b, and 
c, + 2 series but also two d, fragment ions (dh and 
d,). The d, ion assignment was confirmed in the 
Z5*Cf-PDMS spectrum of a doubly acetylated deriva- 
tive of bradykinin that was a by-product of the de- 
sired single acetylation reaction. The masses of the 
intense an-series fragmentation pattern indicated that 
the second ace@ group was located on the side chain 
of the serine residue with the mass of the d,-fragment 
ion indicating loss of an acetyl group from the acety- 
lated side chain of serine. 
The series of x,, yn + 2, z, + 1 backbone fragment 
ions with the positive charge located in the C-terminal 
region was also identified (when the amino acid on 
the C-terminal side of the cleavage site is proline, 
x, + 1 and yn ions are observed). In addition, six 
C-terminal fragmentations, consisting of three v,, (v,, 
v,, and vs) and three w,, (w,, wr, and wa) fragment 
ions, were also observed. 
Negu t ive Ion Spectra 
The negative ion spectra of bradykinin and the two 
derivatives were also examined to determine whether 
any sequence-specific ions could be detected. The 
deprotonated molecular negative ion was observed 
for the parent molecule and the N-acetyl derivative 
but not for the 0-methylated derivative. These spec- 
tra are shown in Figure 5. The absence of the negative 
molecular ion for the methyl ester is direct confrrma- 
tion that deprotonation for bradykinin is occurring 
5.00 
3.00 
b 
r( 
x (M-H, 
5.oa 
0 a 
a Y 3.00 
a 
u 
_, 
.I 
1.00 -s!!w 
7.00 j c 
900 loo0 1100 
5.00 
i 
Ma&s (m/r) 
Figure 5. Negative ion plasma desorption mass spectra of (a) 
N-acetylated bradykinin, (b) bradykinin, and (c) 0-methylated 
bradykin. 
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from the C-terminal carboxyl group. Although there is 
some evidence for loss of small neutral molecules 
from the negative molecular ion (possibly CO, N2), no 
sequence-specific fragment ions could be detected in 
the negative ion spectrum. The intensity of the IM-H] - 
ion for bradykiin is also only 2% of what was mea- 
sured for the [M + HI+ ion. 
Comparison with Fragmentation Patterns for 
Brudykinin Obtained by Other Methods 
Part of the motivation for carrying out this study was 
to determine how the fragmentation pattern obtained 
for bradykinin by 2s2Cf-PDMS compared with what 
has been obtained by other methods. The 252Cf-PDMS 
method is markedly different from the other methods 
in two important respects. One of these is the time 
factor, and this is related to the experimental condi- 
tions at the ion source and the properties of the 
time-of-flight (TOF) method. When a bradykinin 
molecular ion is desorbed from the surface of the 
target, it is accelerated to its full energy in 108 ns in 
our spectrometer. If the molecular ion fragments after 
it leaves the acceleration region, the product species 
will contribute to the intensity of the molecular ion in 
the mass spectrum and not to the fragment ion spec- 
trum. In order for a fragment ion to appear as a sharp 
peak in the mass spectrum at a TOF corresponding to 
its mass-to-charge ratio, the fragmentation must occur 
very close to the surface of the target and within 1 ns 
of excitation by the fission fragment. Thus, the frag- 
mentation pathways available in 252Cf-PDMS under 
these experimental conditions are restricted to only 
those that occur on a subnanosecond time scale. This 
time domain is quite different from the microsecond 
to millisecond sampling times that prevail in a FAB 
source, collision cells, and multisector instruments. 
The other major difference is the method of excita- 
tion of the molecule to a level where fragmentation 
occurs. In 252Cf-J?DMS, the energy density in the 
region around the fission track is equivalent to tem- 
peratures between 5000 and 10,000 K [21]. High fluxes 
of photons and electrons are ejected from the fission 
track that can induce molecular excitation possibly to 
energy regimes not accessible by using other excita- 
tion methods. Direct electronic excitation of a molecule 
by a fission fragment is also possible because of the 
fission fragment’s high atomic charge and velocity. 
The mechanisms of molecular excitation in 252Cf- 
PDMS are very complex and quite different from 
what occurs in a FAB source, a collision cell, or by 
laser photon excitation. With these differences in the 
time and energy domain in mind, we can now com- 
pare our results with what has been reported in the 
literature using other methods. 
The frrst reported mass analysis of the ions from 
bradykii produced in a FAB source clearly revealed 
the presence of fragment ions formed by metastable 
decay of the protonated molecular ion, but much of 
the spectrum in the fragmentation ion region was 
obscured by the high density of background peaks 
[12]. An improved spectrum was published a year 
Later by Martin et al. [22] that showed the metastable 
ion fragmentation pattern more clearly. Only a few of 
the sequence ions were observed, and those were 
centered around the phenylalanine residue with the 
dominant ion being the cs + 2 species. This pattern, 
when compared to what we obtained by 252Cf-PDMS, 
clearly shows that the excitation energy for bradykinin 
is different than what occurs in a FAB source. Re- 
cently, a prominent long-lived metastable ion frag- 
mentation pathway was reported for bradykinin 
involving loss of the C-terminal arginine residue fol- 
lowed by rearrangement to retain one of the C-termi- 
nal carbonyl oxygens [13], giving rise to an ion at m /z 
905 (904 u monoisotopic mass). We searched for this 
fragment ion in the 25ZCf-PD mass spectrum but were 
unable to detect it. Two other fragment ions (ys and 
cs + 2) in the same mass region (m/z 905, 904) have 
been identified as components of the peak observed 
in the 252Cf-PD spectrum at m/z 903.95 (Figure 4b) 
from the mass shifts observed in the derivation stud- 
ies. This fragment ion wouId have been a component 
of the m/z 904 peak in the mass spectrum of the 
bradykinin methyl ester (Figure 4~). However, the 
intensity of the observed peak is consistent with that 
observed for the C, + 2 fragment ion in the spectrum 
for the N-acetyl derivative (Figure 4a). We conclude 
that this rearrangement fragmentation pathway does 
not occur within the nanosecond decay time window 
of “2Cf-PD desorption/ionization. 
Laser desorption has also been used to obtain 
metastable ion spectra of bradykinin [23]. The frag- 
ment ions observed are associated with backbone 
cleavage of the peptide. No side chain cleavages were 
detected. A peculiar feature of the spectrum was the 
absence of the molecular ion, which may indicate that 
the fragment ions observed may actually have been 
due to photolysis of the peptide in the solid state. 
This process can occur when a location on the surface 
of the sample is excited by multiple laser pulses [24]. 
The comparison of the metastable FAB mass spec- 
tra of bradykinin with the metastable 252Cf-PD mass 
spectra clearly indicates that the degree of internal 
excitation of bradykinin is much higher for 252Cf- 
PDMS. The appearance of an abundance of side-chain 
fragment ions (i.e., d,, v,, w,,) is a clear indication 
that this is indeed the case. 
The most successful means to date for inducing 
excitation in bradykinin to dissociative states that give 
abundant sequence-specific ions has been CID. Previ- 
ous studies have focused on two different energy 
regimes that are attained by exciting ions with low 
(15-100 eV) and high (> 5 keV) kinetic energy cofli- 
sions. PouIter and Taylor [14] have recently made a 
comparison of the collision-induced fragmentation 
processes for the two energy regimes and have con- 
cluded that only at high collision energy are the 
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charge-remote site fragmentations and side-chain 
fragmentations of bradykinin observed. Both the 
charge-remote site and side-chain fragmentations are 
observed in the 252Cf-PDMS of bradykinin and in FAB 
followed by high energy CID. The amino acids that 
generate d,, v,, and w, fragment ions by 
FABCID (high energy) [25, 261 are also present in the 
252Cf-PD mass spectrum of bradykinin. We conclude 
that the excitation spectrum for bradykinin populated 
in 252Cf-PDMS is close to that achieved by high en- 
ergy collisions with He gas. 
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